Press Releases Archives - Page 24 of 103 - Lupin

BSE 2281.80 NSE 2316.10

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2281.80 NSE 2316.10

Lupin Receives Approval from U.S. FDA for Tiotropium Dry Powder Inhaler

Lupin Signs MoU with Government of Maharashtra to Combat Rising Prevalence of Cardiovascular Diseases and COPD

Lupin Receives EIR from US FDA for its API Manufacturing Facility in Vizag

Lupin Launches Thiamine Hydrochloride Injection USP in the United States

Lupin Launches Darunavir Tablets in the United States

Lupin Receives Approval from U.S. FDA for Diazepam Rectal Gel

Lupin Receives Approval from U.S. FDA for Obeticholic Acid Tablets

Lupin Announces the Launch of Cetuximab

Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder for Treatment of COPD

Lupin Diagnostics Launches Satellite Laboratory in Vijayawada

1 2 … 23 24 25 … 102 103

Search

Hit enter to search or ESC to close